Ekrem Akdeniz

Prof. Ekrem Akdeniz

Urology, Samsun University, Samsun, Turkey (Türkiye)
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Pan African Medical Journal
Verified
Journal Article
Open access
Ekrem AkdenizEkrem Akdeniz
Ekrem Akdeniz
MBMustafa Bakirtas
Mustafa Bakirtas
MBMustafa Suat Bolat
Mustafa Suat Bolat
SASevda Akdeniz
Sevda Akdeniz
IÖIsmail Özer
Ismail Özer
Neuroendocrine carcinoma is one of the uncommonly seen pathologies of the urinary bladder. Macroscopic hematuria is frequently encountered symptom in patients with neuroendocrine carcinoma. We report a 45-year-old man with left solitary kidney and oliguria for five days the development of acute renal failure (ARF) with impaired general condition. The underlying cause being identified as pure type large-cell neuroendocrine carcinoma of the bladder. Large-cell neuroendocrine carcinoma of the bladder is an uncommon fatal tumor. No macroscopic hematuria or urological symptom was observed in our case. Advanced ectasia was not observed in the kidney, and the patient's clinical status was complicated with ARF. It must not be forgotten than in some bladder tumors, the patient's general condition may be impaired without urological symptoms.

25 May 2018 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
MBMustafa Suat Bolat
Mustafa Suat Bolat
OCOnder Cinar
Onder Cinar
Ekrem AkdenizEkrem Akdeniz
Ekrem Akdeniz
RARamazan Aşcı
Ramazan Aşcı

1 January 2019 in Urology Research and Practice
Verified
Journal Article
Closed access
MBMustafa Suat Bolat
Mustafa Suat Bolat
ÖÇÖnder Çınar
Önder Çınar
Ekrem AkdenizEkrem Akdeniz
Ekrem Akdeniz
EYEmrah Yürük
Emrah Yürük
AMAhmet Yaser Müslümanoğlu
Ahmet Yaser Müslümanoğlu
LTLeman Tomak
Leman Tomak
Objective: To investigate the prevalence of Burnout syndrome (BS) with its emotional exhausting (EE), depersonalization (DP), and personal accomplishment (PA) dimensions among Turkish urologists. Material and methods: A total of 2,259 certified Turkish urologists were invited by e-mail to participate in this cross-sectional survey-based study. An online survey was conducted to evaluate three dimensions of BS ie: -EE, DP and PA-and their association with socio-demographic variables of Turkish urologists using the Maslach Burnout Inventory (MBI). Results: Of the 2259 urologists contacted, 362 (with a mean age of 44±9.9 years) completed the survey. The mean EE, DP and PA scores were 16.8±8.7, 6.6±4.6 and 8.2±5.6, respectively. Cronbach’s α reliability co-efficiencies were 0.920 for EE, 0.819 for DP and 0.803 for PA. Antidepressant drug usage was quite prevalent among participants (21.9%), and the most common comorbidity was hypertension (13%). The academic title, age, smoking status, monthly income and relationships between colleagues and employers were associated with BS (p<0.05). Conclusion: The prevalence of BS among Turkish urologists is quite prevalent in terms of EE and DP subscales and may negatively affect the psychosocial status and well-being of the urologists. In this study, a high prevalence of BS has been reported among Turkish urologists. In conclusion the BS could become an important occupational and health problem, if it is not properly managed. Cite this article as: Bolat MS, Yürük E, Çınar Ö, Akdeniz E, Altunrende F, Özkuvancı Ü, et al. The prevalence of Burnout Syndrome among Turkish Urologists: Results of a Nationwide Survey. Turk J Urol 2019; 45(6): 449-55.

1 August 2021 in Journal of the College of Physicians and Surgeons Pakistan
Verified
Journal Article
Open access
MGMetin Gur
Metin Gur
MUMuhammet Bahaettin Ulu
Muhammet Bahaettin Ulu
SCSuleyman Tumer Caliskan
Suleyman Tumer Caliskan
KOKemal Ozturk
Kemal Ozturk
Ekrem AkdenizEkrem Akdeniz
Ekrem Akdeniz
To assess the effectiveness of the use of dexketoprofen, tamsulosin, silodosin, and tadalafil in medical expulsive therapy for distal ureteral stones in male patients. Cohort study. Department of Urology, Gazi Hospital, Samsun, Turkey, from March 2020 to March 2021. Adult males satisfying the inclusion criteria were randomly assigned into dexketoprofen (Group 1), tamsulosin (Group 2), silodosin (Group 3), or tadalafil (Group 4) treatment arms. The primary endpoint consisted of the stone expulsion rate at the end of four weeks, while the secondary endpoints were the expulsion rate after two weeks and the occurrence of adverse events. Clinical findings were then compared among the study groups. Altogether 193 patients, 50 (25.9%) in group 1, 48 (24.9%) in group 2, 49 (25.4%) in group 3, and 46 (23.8%) in group 4, were enrolled in the study. No significant difference was determined in terms of age, body mass index, stone characteristics, expulsion time, pain episodes, or total analgesic consumption among the four groups. Expulsion rates in the fourth week were 48%, 79.2%, 81.6%, and 78.3% in groups 1, 2, 3, and 4, respectively. Stone expulsion rates were significantly greater in groups 2, 3, and 4 compared to group 1 (p <0.001), but no significant differences were determined between groups 2, 3, and 4. No severe adverse effects occurred throughout the study period. Tamsulosin, silodosin and tadalafil exhibited higher expulsion rates for distal ureteral stones in male patients, although none was significantly superior to the others. All three are safe, efficacious, and well-tolerated, with only very minor side-effects. Key Words: Dexketoprofen, Distal ureteral stones, Medical expulsive therapy, Silodosin, Tadalafil, Tamsulosin.

1 January 2019 in Urology Research and Practice
Verified
Journal Article
Closed access
MBMustafa Suat Bolat
Mustafa Suat Bolat
MBMustafa Bakırtaş
Mustafa Bakırtaş
FFFatih Fırat
Fatih Fırat
Ekrem AkdenizEkrem Akdeniz
Ekrem Akdeniz
ÖÇÖnder Çınar
Önder Çınar
FEFikret Erdemir
Fikret Erdemir
Objective: A debate is open on the effects of lipid-lowering drugs on sexual function. We aimed to investigate the effect of atorvastatin use on penile intracavernosal pressure (ICP) and cavernosal morphology. Material and methods: Fourteen mature male Sprague-Dawley-rats were randomly assigned to either the control group (which received standard food and water ad libitum) or the atorvastatin group (which received standard food, water, and statin) for twelwe weeks. At the end of the study, ICPs were measured with cavernosometry. Penectomy specimens were histologically examined. Results: The following mean values were obtained for the control and atorvastatin groups, respectively: pre-study body weights (350±16.9 g and 331.4±24.9 g); post-study body weights (356±18 g and 368±22.5 g (p>0.05); ICPs at 5 V (5.96±5.16 mmHg and 2.11±1.22 mmHg (p=0.07)); ICPs at 10 V (18.28±14.1 mmHg and 5.56±5.58 mmHg) (p=0.09); testosterone (1.23±0.78 and 0.78±0.58 mmol/dL) (p=0.39); blood glucose (151±22 mg/dL and 168.6±16.2 mg/dL) (p=0.12); triglyceride (93.4±19.8 mg/dL and 52.1±18.6 mg/dL) (p=0.01); total cholesterol (50.2±7.2 mg/dL and 47.7±6.6 mg/dL) (p=0.51); and low-density lipoprotein (LDL) cholesterol (10.0±4.4 mg/dL and 3.5±2.1 mg/dL) (p=0.01). The mean collagen thickness was similar (p=0.09); but the mean elastin thickness increased in the atorvastatin group (p=0.01). Conclusion: The present study showed that the use of atorvastatin reduced the intracavernosal pressure in 10 V stimulation, and minimally decreased testosterone levels in rats, within a short period of time. When statin treatment is considered for its protective properties on cardiovascular system or for its lipid-lowering effect. It should be kept in mind that atorvastatin may also adversely contribute to erectile dysfunction. Cite this article as: Bolat MS, Bakırtaş M, Fırat F, Akdeniz E, Çınar Ö, Erdemir F. The effect of atorvastatin on penile intracavernosal pressure and cavernosal morphology in normocholesterolemic rats. Turk J Urol 2019; 45(2): 91-6.

21 November 2017 in Pain Medicine
Verified
Journal Article
Closed access
PDF file
Ekrem AkdenizEkrem Akdeniz
Ekrem Akdeniz
MBMustafa Suat Bolat
Mustafa Suat Bolat
SASevda Akdeniz
Sevda Akdeniz
The purpose of this study was to evaluate the analgesic effect of a prilocaine + bupivacaine combination in patients undergoing periprostatic nerve block (PNB) by comparing its effects with those of prilocaine alone. Single center, single-blind, prospective descriptive study. Four hundred patients with transrectal prostate biopsy pain. The patients in this prospective, randomized controlled study were divided into two groups. The first group received prilocaine during PNB (Group 1), whereas the second received a prilocaine + bupivacaine combination (Group 2). The mean visual analog scale (VAS) scores immediately after biopsy were 2.52 ± 0.7 and 2.53 ± 0.9, respectively (P = 0.35). VAS values were significantly lower in Group 2 at one and six hours following the procedure. The most painful part of the biopsy according to many patients was the probe insertion. The prilocaine + bupivacaine combination is an effective analgesic method during prostate biopsies and for one and six hours after prostate biopsy.